English flagItalian flagKorean flagChinese (Simplified) flagPortuguese flagGerman flagFrench flagJapanese flagArabic flagRussian flag
Dutch flagCzech flagDanish flagHindi flagRomanian flagSwedish flagNorwegian flagIndonesian flag  

iSoft’s CEO quits after $383m plunge

ISOFT chief executive Gary Cohen has quit less than three months after relinquishing the chairman role after a horror full-year result. The Sydney health information technology company yesterday reported a $382.9 million loss, following a $34.7m profit last year, that included a hefty $341m one-off impairment charge, primarily related to ...

High-Profit Hospitals

The average American hospital barely breaks even. But some are enormous profit centers. Forbes’ first-ever survey of America’s most profitable hospitals reveals that some American hospitals make 25 cents or more for every $1 in patient revenue they take in. Our list, done by the American Hospital Directory, is based ...

Stockland underweight in bid for Aevum

FROM the moment Stockland announced a hostile cash offer for Aevum, the market has been telling Stockland it must offer more. On August 2, Stockland offered $1.50 a share; a premium of 37.6 per cent to retirement village operator Aevum’s previous closing price of $1.09 and 32.7 per cent to ...

J&J recalls hip replacement parts

A surgeon studies a patient’s X-ray as he performs a hip replacement JOHNSON & Johnson is recalling hip replacement parts implanted in about 93,000 people worldwide, due to a high rate of repeat surgeries. The recall adds a further quality problem for the health-products giant. A Johnson & Johnson spokesman ...

Ramsay baulks at British rival

RAMSAY Health Care remains committed to building its European presence but has stopped short of chasing British rival Spire Healthcare. Spire’s private equity backers are known to be willing sellers. Spire is the second-largest private hospital group in Britain, operating 36 acute-care hospitals. It has an Australian management team led ...

Ramsay baulks at British rival

RAMSAY Health Care remains committed to building its European presence but has stopped short of chasing British rival Spire Healthcare. Spire’s private equity backers are known to be willing sellers. Spire is the second-largest private hospital group in Britain, operating 36 acute-care hospitals. It has an Australian management team led ...

Sonic seeks healthier markets overseas

SONIC Healthcare will increasingly focus its growth plans overseas while the outlook for the Australian pathology market remains uncertain. Delivering a full-year profit crimped by recent cuts to Medicare fees for pathology services, Sonic’s outspoken chief executive, Colin Goldschmidt, warned that further cuts would seriously damage the industry. “We . ...

NIB focuses on growth

HEALTH insurer NIB Holdings is confident of earnings growth next year after a 158 per cent rise in its full-year net profit to $61.5 million. Managing director Mark Fitzgibbon said NIB policy holders increased by 5.9 per cent to 22,641 compared with the industry average of 2.9 per cent. “The ...

Top Back-To-School Health Tips

Parents have plenty of health risks to worry about that weren’t an issue when they were growing up. Like videogames, which experts say are keeping children too sedentary and preventing them from sleeping. Or drug-resistant bacteria like methicillin-resistant staphylococcus aureus (MRSA), which causes painful skin infections. It’s gone from a ...

Deadlock ‘bad news for reform’

KEY planks of Julia Gillard’s health reform program have been thrown into doubt Experts are warning the chance of significant changes to the system have probably evaporated along with Labor’s parliamentary majority. Health experts say even if Labor succeeds in forming a minority government, its fragility would probably prevent it ...

CSL in McNamee’s blood

THE prospect of Olympic glory came close to tempting Brian McNamee away from his job at CSL. Having been appointed head of the struggling former government enterprise when he was just 33 years old, McNamee was fortunate that his role seemed to continually evolve and he never had to look ...

CSL has no acquisition in its sights

CSL CEO Brian McNamee Source: The Australian CSL will undertake another multi-million-dollar share buyback, having all but ruled out major corporate activity this year. Four months after finalising a $1.8 billion return to investors, the pharmaceutical company has announced a fresh $900 million buyback, citing strong cashflows and a sound ...